Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Adenine Dinucleotide, Dihydronicotinamide
2. Coenzyme I
3. Dihydronicotinamide Adenine Dinucleotide
4. Dinucleotide, Dihydronicotinamide Adenine
5. Dinucleotide, Nicotinamide-adenine
6. Diphosphopyridine Nucleotide
7. Dpn
8. Nad
9. Nadh
10. Nicotinamide Adenine Dinucleotide
11. Nicotinamide-adenine Dinucleotide
12. Nucleotide, Diphosphopyridine
1. Nad+
2. 53-84-9
3. Coenzyme I
4. Beta-nad
5. Codehydrase I
6. Codehydrogenase I
7. Nicotinamide Adenine Dinucleotide
8. Beta-nad+
9. Cozymase I
10. Diphosphopyridine Nucleotide
11. Beta-nicotinamide Adenine Dinucleotide
12. Beta-diphosphopyridine Nucleotide
13. Cozymase
14. Nicotinamide Dinucleotide
15. Co-i
16. Enzopride
17. Nad
18. Nadidum
19. Nad Zwitterion
20. Oxidized Diphosphopyridine Nucleotide
21. Co-1
22. Pyridine, Nucleotide Diphosphate
23. Nicotineamide Adenine Dinucleotide
24. Nicotinamide-adenine Dinucleotide
25. Beta-dpn
26. Adenine-nicotinamide Dinucleotide
27. Codehydrogenase
28. Nadidum [inn-latin]
29. Nadida [inn-spanish]
30. Nicotinamide Adenine Dinucleotide Oxidized
31. Beta-diphosphopyridinenucleotide
32. Chebi:44215
33. Brn 3584133
34. Diphosphopyridine Nucleotide Oxidized
35. Nad Trihydrate
36. 3-carbamoyl-1-beta-d-ribofuranosylpyridinium Hydroxide, 5'-ester With Adenosine 5'-pyrophosphate, Inner Salt
37. Nad-oxidized
38. Nicotinamide Adenine Dinucleotide (nad)
39. Nicotinamide-adenine-dinucleotide
40. Mfcd00036253
41. Nsc 20272
42. Dpn-ox
43. .beta.-nad
44. 64417-72-7
45. Nad Lithium Salt
46. Endopride
47. Adenosine 5'-(trihydrogen Diphosphate), P'-5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium Hydroxide, Inner Salt
48. Dpn+
49. Nad+, Free Acid
50. Nadida
51. Adenosine 5'-(trihydrogen Diphosphate), P'-5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt
52. 0u46u6e8uk
53. 1-((2r,3r,4s,5r)-5-((((((((2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium
54. Nsc-20272
55. Nadide [usan:inn:ban:jan]
56. Pyridinium, 3-carbamoyl-1-beta-d-ribofuranosyl-, Hydroxide, 5'-ester With Adenosine 5'-5'-(trihydrogen Pyrophosphate), Inner Salt
57. Einecs 200-184-4
58. Unii-0u46u6e8uk
59. Nadlithiumsalt
60. Nsc20272
61. Cas-53-84-9
62. B-nicotinamide Adenine Dinucleotide
63. Ncgc00016240-01
64. B-dpn
65. B-nad
66. Beta-nicotinamide Adenine Dinucleotide Hydrate
67. [adenylate-32-p]-nad
68. Carbonyl [14c] Nad+
69. Ec 200-184-4
70. Nad, Grade I, Free Acid
71. [adenylate-32-p]-nad+
72. Dsstox_cid_25236
73. Dsstox_rid_80768
74. Nad, Grade Ii, Free Acid
75. Dsstox_gsid_45236
76. 5-26-16-00399 (beilstein Handbook Reference)
77. Schembl131544
78. Spectrum1500419
79. Pyridine Nucleotide Diphosphate
80. Gtpl2451
81. Chembl1234613
82. Dtxsid2045236
83. Hms500j11
84. Nicotinamide Adinine Dinucleotide
85. [14c] Nad+
86. [32p] Nad+
87. Bdbm213227
88. Hms2091h06
89. Hms2097e04
90. Hms3714e04
91. Pharmakon1600-01500419
92. Ex-a3535
93. Hy-b0445
94. Tox21_110321
95. Ccg-40114
96. Nsc757121
97. S2518
98. Akos015892319
99. Beta-nicotinamide Adenine Din-ucleotide
100. Db14128
101. Nsc-757121
102. .beta.-nicotinamide Adenine Dinucleotide
103. Ncgc00178839-01
104. Ncgc00178839-02
105. Ncgc00178839-03
106. Ncgc00178839-08
107. [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl Phosphate
108. Adenosine 5'-(trihydrogen Diphosphate), 5'-5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Hydroxide, Inner Salt
109. As-14652
110. Sbi-0051451.p003
111. Ab00513910
112. D0919
113. Beta-nicotinamide Adenine Dinucleotide, Reduced
114. Ab00052048_03
115. Beta-nicotinamide Adenine Dinucleotide Trihydrate
116. Beta-nicotinamide Adenine Dinucleotide Hydrate, >=99%
117. Q12499775
118. F45c0d6c-da87-47be-9975-7a5de9ccb985
119. Beta-nicotinamide Adenine Dinucleotide Hydrate, >=95% (hplc)
120. Beta-nicotinamide Adenine Dinucleotide, Pkg Of 10 Mg (per Vial)
121. Beta-nicotinamide Adenine Dinucleotide, Pkg Of 20 Mg (per Vial)
122. Beta-nicotinamide Adenine Dinucleotide, Pkg Of 50 Mg (per Vial)
123. Beta-nicotinamide Adenine Dinucleotide Hydrate, >=98%, Bioultra, From Yeast
124. Beta-nicotinamide Adenine Dinucleotide Hydrate, Grade Aa-1, >=95% (hplc)
125. 3-carbamoyl-1-d-ribofuranosylpyridinium Hydroxide 5'-ester With Adenosine 5'-pyrophosphate
126. Beta-nicotinamide Adenine Dinucleotide Hydrate, Purified By Column Chromatography, >=99%
127. Beta-nicotinamide Adenine Dinucleotide Hydrate, Vetec(tm) Reagent Grade, >=96.5%
128. [(3s,2r,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3s,2r,4r,5r)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl) Hydrogen Phosphate
129. [(3s,2r,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3s,2r,4r,5r)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl)hydrogen Phosphate
130. [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl Hydrogen Phosphate
131. 3-carbamoyl-1-beta-d-ribofuranosylpyridinium Hydroxide 5'-ester With Adenosine 5'-pyrophosphate Inner Salt
132. 3-carbamoyl-1-beta-delta-ribofuranosylpyridinium Hydroxide 5'-ester With Adenosine 5'-pyrophosphate Inner Salt
133. 3-carbamoyl-1-delta-ribofuranosylpyridinium Hydroxide 5'-ester With Adenosine 5'-pyrophosphate
134. Adenosine 5'-(trihydrogen Diphosphate), P'->5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt
135. Adenosine 5'-(trihydrogen Diphosphate), P'.fwdarw.5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt
136. Adenosine 5'-(trihydrogen Diphosphate-p-32p), P'>5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt (9ci)
137. Beta-nicotinamide Adenine Dinucleotide Hydrate, >=96.5% (hplc), >=96.5% (spectrophotometric Assay), From Yeast
138. Beta-nicotinamide Adenine Dinucleotide Hydrate, Cell Culture Tested, >=96.5% (hplc), >=96.5% (spectrophotometric Assay), From Yeast
139. Beta-nicotinamide Adenine Dinucleotide Hydrate, Pharmagrade, Manufactured Under Appropriate Controls For Use As A Raw Material In Pharma Or Biopharmaceutical Production.
140. Beta-nicotinamide Adenine Dinucleotide Hydrate, Suitable For Manufacturing Of Diagnostic Kits And Reagents
141. Pyridinium, 3-carbamoyl-1-b-d-ribofuranosyl-, Hydroxide, 5'-5'-ester With Adenosine 5'-(trihydrogen Pyrophosphate), Inner Salt (8ci)
| Molecular Weight | 663.4 g/mol |
|---|---|
| Molecular Formula | C21H27N7O14P2 |
| XLogP3 | -6 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 11 |
| Exact Mass | 663.10912256 g/mol |
| Monoisotopic Mass | 663.10912256 g/mol |
| Topological Polar Surface Area | 321 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 1120 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
Details:
Evidence that M041, phosphorylated alpha-N-acetylglucosaminidase, has improved trafficking and binding to M6P receptors. M041 has markedly improved cellular uptake in patient fibroblasts when compared to wild type alpha-N-acetylglucosaminidase.
Lead Product(s): M041
Therapeutic Area: Genetic Disease Brand Name: M041
Study Phase: PreclinicalProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 02, 2022
Lead Product(s) : M041
Therapeutic Area : Genetic Disease
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
M6P Therapeutics to Participate in Key Event Highlights at WORLDSymposium™ 2022 and Present Prec...
Details : Evidence that M041, phosphorylated alpha-N-acetylglucosaminidase, has improved trafficking and binding to M6P receptors. M041 has markedly improved cellular uptake in patient fibroblasts when compared to wild type alpha-N-acetylglucosaminidase.
Brand Name : M041
Molecule Type : Large molecule
Upfront Cash : Not Applicable
February 02, 2022
Details:
As the study suggests, M6PT’s M041 recombinant enzyme therapy (NAGLUM6P) employs an efficient and well-trafficked lysosomal enzyme as the key to developing a potentially effective therapy to treat this rare pediatric disorder.
Lead Product(s): M041
Therapeutic Area: Genetic Disease Brand Name: M041
Study Phase: PreclinicalProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 28, 2021
Lead Product(s) : M041
Therapeutic Area : Genetic Disease
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
M6P Therapeutics Presented Data on M041
Details : As the study suggests, M6PT’s M041 recombinant enzyme therapy (NAGLUM6P) employs an efficient and well-trafficked lysosomal enzyme as the key to developing a potentially effective therapy to treat this rare pediatric disorder.
Brand Name : M041
Molecule Type : Large molecule
Upfront Cash : Not Applicable
July 28, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A M041 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of M041, including repackagers and relabelers. The FDA regulates M041 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. M041 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A M041 supplier is an individual or a company that provides M041 active pharmaceutical ingredient (API) or M041 finished formulations upon request. The M041 suppliers may include M041 API manufacturers, exporters, distributors and traders.
M041 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of M041 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right M041 GMP manufacturer or M041 GMP API supplier for your needs.
A M041 CoA (Certificate of Analysis) is a formal document that attests to M041's compliance with M041 specifications and serves as a tool for batch-level quality control.
M041 CoA mostly includes findings from lab analyses of a specific batch. For each M041 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
M041 may be tested according to a variety of international standards, such as European Pharmacopoeia (M041 EP), M041 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (M041 USP).
LOOKING FOR A SUPPLIER?
